SUPN (STOCKS)
Supernus Pharmaceuticals, Inc.
$47.150000
-0.720000 (-1.50%)
Prev close: $47.870000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jack A. Khattar
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,849.08M
- Employees
- 674
- P/E (TTM)
- -25.01
- P/B (TTM)
- 2.70
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $830.44M |
| Benefits Costs and Expenses | $953.90M |
| Cost Of Revenue | $99.03M |
| Costs And Expenses | $960.90M |
| Gross Profit | $731.41M |
| Nonoperating Income/Loss | $7.00M |
| Operating Expenses | $861.87M |
| Selling, General, and Administrative Expenses | $560.88M |
| Depreciation and Amortization | $1.90M |
| Research and Development | $126.09M |
| Other Operating Expenses | $173.00M |
| Operating Income/Loss | -$130.46M |
| Income/Loss From Continuing Operations After Tax | -$109.89M |
| Income/Loss From Continuing Operations Before Tax | -$123.47M |
| Income Tax Expense/Benefit | -$13.58M |
| Income Tax Expense/Benefit, Deferred | $5.33M |
| Net Income/Loss | -$109.89M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$109.89M |
| Net Income/Loss Available To Common Stockholders, Basic | -$109.89M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.92 |
| Diluted Earnings Per Share | -$1.92 |
| Basic Average Shares | 114,730,090 |
| Diluted Average Shares | 114,730,090 |
| Assets | $1.43B |
| Current Assets | $723.50M |
| Inventory | $107.03M |
| Other Current Assets | $616.47M |
| Noncurrent Assets | $704.61M |
| Fixed Assets | $10.20M |
| Intangible Assets | $469.46M |
| Other Non-current Assets | $224.96M |
| Liabilities | $396.88M |
| Current Liabilities | $347.38M |
| Accounts Payable | $5.59M |
| Wages | $24.36M |
| Other Current Liabilities | $317.43M |
| Noncurrent Liabilities | $49.51M |
| Equity | $1.03B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.03B |
| Liabilities And Equity | $1.43B |
| Net Cash Flow From Operating Activities | $19.91M |
| Net Cash Flow From Operating Activities, Continuing | $19.91M |
| Net Cash Flow From Investing Activities | -$14.73M |
| Net Cash Flow From Investing Activities, Continuing | -$14.73M |
| Net Cash Flow From Financing Activities | $31.51M |
| Net Cash Flow From Financing Activities, Continuing | $31.51M |
| Net Cash Flow | $36.69M |
| Net Cash Flow, Continuing | $36.69M |
| Comprehensive Income/Loss | -$109.82M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$109.82M |
| Other Comprehensive Income/Loss | -$109.82M |
| Other Comprehensive Income/Loss Attributable To Parent | $62.00K |